The last decade has seen a renewed interested in a risk-adapted approach to the
management of differentiated thyroid cancer (DTC), in which specific treatment and follow-up …

Objective To validate the A merican T hyroid A ssociation ( ATA ) initial risk of recurrence
scheme and the M emorial S loan K ettering C ancer C enter ( MSKCC ) response to therapy re‐…

Background: Age is a critical factor in outcome for patients with well-differentiated thyroid
cancer. Currently, age 45 years is used as a cutoff in staging, although there is increasing …

Context: Although response to therapy assessment is a validated tool for dynamic risk
stratification in patients with differentiated thyroid cancer (DTC) treated with total thyroidectomy (TT…

Background: In most staging systems, 45 years of age is used to differentiate low risk thyroid
cancer from high risk thyroid cancer. However, recent studies have questioned both the …

Background and Objective. An individualized risk-based approach to the treatment of thyroid
cancer is being extensively discussed in the recent literature. However, controversies about …

AIMS: The present study evaluated the relationship between metabolic syndrome (MS), body
fat composition and epicardial adipose tissue (EAT) in type 1 diabetes. Epicardial adipose …

The effects of LASSBio596, a phosphodiesterase type‐4 and ‐5 inhibitor, were tested in
Escherichia coli lipopolysaccharide (LPS)-induced acute lung injury. Twenty-four BALB/c mice …

Objective: Bone metastases bring greater morbi-mortality to patients with differentiated thyroid
carcinoma (DTC). Treatment was limited to radioactive iodine (RAI) and local approaches. …

The incidence of differentiated thyroid cancer (DTC) is increasing worldwide, especially among
small (≤2 cm) tumors. Overall, small DTC have an excellent prognosis and low mortality …